How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population?

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3943-3950

  Castledine, Clare I ^a   Gilg, Julie A ^a   Rogers, Chris ^b   Ben Shlomo, Yoav ^b   Caskey, Fergus J ^a,b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

access to healthcare; diabetes; hypertension; incidence; renal replacement therapy

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR MORTALITY; CHILD; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INFANT; KIDNEY FAILURE; KNEE ARTHROPLASTY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SOCIAL STATUS; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH STATUS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL REPLACEMENT THERAPY; SOCIAL CLASS;

EID: 84868546143     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs294     Document Type: Article

References (43)

1. Byrne C, Ford D, Gilg J et al. UK ESRD Incident Rates in 2008: national and centre-specific analyses. Nephron Clin Prac 2010; 115 (Suppl 1): c9-c39
2. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis 2006; 47: 445-55
3. Wimmer F, Oberaigner W, Kramar R et al. Regional variability in the incidence of end-stage renal disease: an epidemiological approach. Nephrol Dial Transplant 2003; 18: 1562-1567
4. Van Dijk PCW, Jager KJ, Stengel B et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499
5. Stengel B, Billon S, van Dijk P et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 2003; 18: 1824-1833
6. The ESRD Incidence Study Group. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 2006; 21: 2178-2183
7. Kastarinen M, Juutilainen A, Kastarinen H et al. Risk factors for endstage renal disease in a community-based population: 26-year followup of 25 821 men and women in eastern Finland. J Intern Med 2009; 267: 612-620
8. Ejerblad E, Fored CM, Lindblad P et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004; 15: 2178-2185
9. Hsu C-y, Iribarren C, McCulloch CE et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-350
10. Hsu C-y, Vittinghoff E, Lin F et al. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141: 95-101
11. O'Hare AM, Rodriguez RA, Hailpern SM et al. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. J Am Med Assoc 2010; 304: 180-186
12. Muntner P, Coresh J, Powe NR et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003; 14: 1568-1577
13. McDonald S, McCredie M, Williams S et al. Factors influencing reported rates of treated end-stage renal disease. Adv Chronic Kidney Dis 2005; 12: 32-8
14. Buch P, Rasmussen S, Gislason GH et al. Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002. Heart 2007; 93: 210-215
15. Agarwal R, Bunaye Z, Bekele D et al. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 2008; 28: 569-575
16. Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Curr Opin Nephrol Hypertens 2008; 17: 286-292
17. Udayaraj U, Ben-Shlomo Y, Roderick P et al. Socio-economic status, ethnicity and geographical variations in acceptance rates for renal replacement therapy in England and Wales: an ecological study. J Epidemiol Community Health 2010; 64: 535-541
18. Ansell D, Feest T. The sixth annual report. Chapter 2: Introduction to the 2003 report. Bristol: UK Renal Registry, 2003
19. Dean CB. Testing for overdispersion in Poisson and binomial regression models. J Am Stat Assoc 1992; 87: 451-457
20. Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Stat Med 2002; 21: 3291-315
21. http://www.yhpho.org.uk/resource/view.aspx?RID=81090
22. Rose G. Sick individuals and sick populations. Int J Epidemiol 2001; 30: 427-432
23. Volkova N, McClellan W, Klein M et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008; 19: 356-364
24. Castledine C, Gilg J, Rogers C et al. Chapter 15: RRT incidence and use of home dialysis modalities. Nephron Clin Prac 2011; 119 (Suppl 2): c255-c267.
25. Roderick P, Ferris G, Feest T. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions. QJM 1998; 91: 581-587
26. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
27. Ismail-Beigi F, Craven T, Banerji MA et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376: 419-430
28. Batlle D, Ramadugu P, Soler MJ. Progress in retarding the progression of advanced chronic kidney disease: grounds for optimism. Kidney Int 2006; 70 (S104): S40-S44
29. Whincup PH, Kaye SJ, Owen CG et al. Birth weight and risk of type 2 diabetes: a systematic review. J Am Med Assoc 2008; 300: 2886-2897
30. Woods LM, Rachet B, Riga M et al. Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health 2005; 59: 115-120
31. Greco B, Beyer J. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol 1996; 16: 2-11
32. Scoble J. The epidemiology and clinical manifestations of atherosclerotic renal disease. In: Novick AC, Scoble J, Hamilton G (eds). Renal Vascular Disease. London: HBJ College & School Division, 1996, pp. 303-314
33. Krijnen P, van Jaarsveld BC, Steyerberg EWet al. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129: 705-711
34. Novick A. Patient selection for intervention to preserve renal function in ischemic renal disease. In: Novick AC, Scoble J, Hamilton G (eds). Renal Vascular Disease. London: HBJ College & School Division, 1996, pp. 323-337
35. Chade AR, Rodriguez-Porcel M, Grande JP et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002; 106: 1165-1171
36. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382
37. Geller S, Burns L, Brailer D. The impact of nonclinical factors on practice variations: the case of hysterectomies. Health Serv Res 1996; 30: 729-750
38. Ward PR, Noyce PR, St Leger AS. Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. J Epidemiol Community Health 2004; 58: 89-96
39. Spiegel B, Bolus R, Desai AA et al. Dialysis practices that distinguish facilities with below-versus above-expected mortality. Clin J Am Soc Nephrol 2010; 5: 2024-2033
40. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; doi:10.1093/ndt/gfq781
41. Judge A, Welton NJ, Sandhu J et al. Equity in access to total joint replacement of the hip and knee in England: cross sectional study. Br Med J 2010; 341: c4092.
42. http://www.ons.gov.uk/census/index.html
43. Noble M, Wright G, Dibben C et al. The English Indices of Deprivation 2004 [Revised]. London: Office of the Deputy Prime Minister, 2001